Strides Pharma Inc receives USFDA closure report (EIR) for its formulations facility at Chestnut Ridge New YorkInspection included Drug Device Combinations covering our recent filing in Nasa Sprays domain
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]